Liver Injury After CAR T-Cell Therapy May Be Driven by Cytokine Storm, Landmark Analysis Finds
A pharmacovigilance analysis of nearly five million adverse-event reports finds that liver injury after CAR T-cell therapy is predominantly early ...
A pharmacovigilance analysis of nearly five million adverse-event reports finds that liver injury after CAR T-cell therapy is predominantly early ...
A retrospective review of 35 published cases shows that nivolumab can trigger cytokine release syndrome weeks to months into treatment, ...
A comprehensive new review maps how clinicians are taming cytokine release syndrome, the most dangerous side effect of CAR T-cell ...
Updated 2026 expert recommendations provide a comprehensive, evidence-graded framework for preventing, diagnosing and treating the rare but often fatal myocarditis ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine